United States Specialty Generics Market Share, Size, Growth, Opportunity and Forecast 2022-2027

[vishal]

The IMARC Group provides extensive analysis of the United States specialty generics industry covering the market trends, investment opportunities, growth trends, statistics, and industry prospects. The report offers a comprehensive analysis of the industry, which comprises insights on United States specialty generics market size, share, trends, analysis, growth, demand, statistics, and overview. The report also includes competitor and regional analysis, and contemporary advancements in the global market.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report. The market is segmented by size and region. The report provides an analysis of the key trends in each sub-segment of the market, along with forecasts at the global and regional level from 2022-2027. The report also includes competitive landscape of major key players in the industry along with emerging trends in the market.

Informed covered in the report:

• Historical market data from 2016-2021
• CAGR of the market during the forecast period 2022-2027
• Detailed information on factors that will drive market growth during the next five years
• Precise estimation of the Keyword market size and its contribution to the parent market
• Upcoming market trends and changes in consumer behavior
• A thorough analysis of the market’s competitive landscape and detailed information on key players
• Comprehensive details of factors that will challenge the growth of smart meters market key players

Note: We are updating our reports, If you want the latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you via email within 24 to 48 hours.”

Request for a PDF sample of this report: https://www.imarcgroup.com/united-states-specialty-generics-market/...

the United States specialty generics market reached a value of US$ 21 Billion in 2020. Specialty generics refer to the generic variants of branded specialty drugs, which are only developed once the patent expires. These drugs are available only on prescriptions and are utilized to treat chronic medical conditions such as cancer, rheumatoid arthritis, inflammatory bowel disease (IBD), HIV, psoriasis, hemophilia, multiple sclerosis, epilepsy, and hepatitis C. As the prevalence of these diseases is rising gradually in the United States, there is a high demand for specialty generic drugs. Moreover, favorable initiatives by the US Food and Drugs Administration (FDA), such as the breakthrough therapy designation, aimed to smoothen the accessibility to these drugs.

United States Specialty Generics Market Trends:

Specialty generic drugs are more cost-effective than their branded counterparts. This can be accredited to the elimination of time-consuming research and development (R&D) activities and low cost requirements for their marketing and promotion. As a result, they help in reducing the overall cost of the treatment, which has increased the inclination toward these drugs. Apart from this, the rising prevalence of life-threatening diseases and the growing geriatric population are contributing to the growth of the market. According to statistics, the United States is experiencing steady growth in the number of cancer cases. In 2020, an estimated 1,806,590 new cancer cases are expected to be diagnosed among adolescents and young adults (15-39 years) and 606,520 people can die from the disease. With these numbers aggravating every year, the demand for specialty generics will increase subsequently. Additionally, several blockbuster drugs will lose patent protection in the near future, which is creating a positive outlook for the market.

Key Market Segmentation:

The report has segmented the United States specialty generics market on the basis of route of administration, therapeutic application and distribution channel.

Market Breakup by Route of Administration:

• Injectables
• Oral
• Others

Market Breakup by Therapeutic Application:

• Oncology
• Hepatitis
• Multiple Sclerosis
• HIV
• Other Autoimmune Diseases
• Others

Market Breakup by Distribution channel:

• Retail Pharmacies
• Specialty Pharmacies
• Hospital Pharmacies

Explore full report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=1273&flag=C

Key highlights of the report:

• Market Performance (2016-2021)
• Market Outlook (2022- 2027)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

About Us:                                                                     

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA – Wyoming

Email: [e-mail]

Tel No:(D) [phone]

Americas: - [phone] | Africa and Europe: - [phone] | Asia: [phone]